MCID: URT004
MIFTS: 45

Urethral Syndrome malady

Categories: Nephrological diseases

Aliases & Classifications for Urethral Syndrome

Summaries for Urethral Syndrome

MedlinePlus : 41 the urethra is the tube that allows urine to pass out of the body. in men, it's a long tube that runs through the penis. it also carries semen in men. in women, it's short and is just above the vagina. urethral problems may happen due to aging, illness, or injury. they include urethral cancer - a rare cancer that happens more often in men urethral stricture - a narrowing of the opening of the urethra urethritis - inflammation of the urethra, sometimes caused by infection urethral problems may cause pain or difficulty passing urine. you may also have bleeding or discharge from the urethra. doctors diagnose urethral problems using different tests. these include urine tests, x-rays and an examination of the urethra with a scope called a cystoscope. treatment depends on the cause of the problem. it may include medicines and, in severe cases, surgery.

MalaCards based summary : Urethral Syndrome, also known as urethral diseases, is related to urethritis and tick-borne relapsing fever, and has symptoms including pain in urethra An important gene associated with Urethral Syndrome is MRAP (Melanocortin 2 Receptor Accessory Protein), and among its related pathways/superpathways is Primary immunodeficiency. The drugs Ethanol and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include testes, prostate and cervix.

Disease Ontology : 12 A urinary system disease that is located in the urethra.

Wikipedia : 71 Urethral syndrome is characterised by a set of symptoms typically associated with lower urinary tract... more...

Related Diseases for Urethral Syndrome

Diseases related to Urethral Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 116)
id Related Disease Score Top Affiliating Genes
1 urethritis 11.0
2 tick-borne relapsing fever 10.3 MRAP PHB2
3 azoospermia 10.3 HPD MRAP
4 acute maxillary sinusitis 10.3 MRAP PHB2
5 vibratory urticaria 10.3 MRAP PHB2
6 cystic kidney disease 10.2 MRAP PHB2
7 uterine corpus epithelioid leiomyoma 10.2 KLK3 SAMHD1
8 diabetic peripheral angiopathy 10.2 CD40LG MRAP
9 angiolipoma 10.2 CD40LG MRAP
10 capillary leak syndrome 10.2 BCKDHA MN1 MRAP
11 hypopituitarism 10.2 CD40LG MRAP
12 oculoauricular syndrome 10.2 CD40LG MT-TG
13 estrogen excess 10.1 CD40LG SAMHD1
14 barbiturate dependence 10.1 CD79A MT-TG
15 alcoholic neuropathy 10.1 CD40LG CD79A
16 camptodactyly vertebral fusion 10.1 CD40LG CD79A
17 spinal polio 10.1 CD40LG CD79A
18 rabies 10.1 CD40LG CD79A
19 unilateral retinoblastoma 10.1 CD40LG CD79A
20 mesangial proliferative glomerulonephritis 10.1 CD40LG CD79A
21 delta chain disease 10.1 CD40LG CD79A
22 discitis 10.1 CD40LG CD79A
23 spinal canal and spinal cord meningioma 10.1 CD40LG CD79A
24 trichostrongyloidiasis 10.1 CD40LG CD79A
25 colloid adenoma 10.1 CD40LG CD79A
26 heart septal defect 10.1 CD40LG CD79A
27 cutaneous polyarteritis nodosa 10.1 CD40LG CD79A
28 mild pre-eclampsia 10.1 CD40LG CD79A
29 retinal microaneurysm 10.1 CD40LG CD79A
30 jaw cancer 10.1 CD40LG ECI1
31 pediatric meningioma 10.1 CD40LG CD79A
32 tonsil cancer 10.1 CD40LG CD79A
33 indomethacin antenatal infection 10.1 CD40LG CD79A
34 postcricoid region cancer 10.1 CD40LG CD79A
35 beach ear 10.1 CD40LG CD79A
36 acute kidney tubular necrosis 10.1 CD40LG CD79A
37 atheroembolism of kidney 10.1 CD40LG CD79A
38 partial sensory epilepsy 10.1 CD40LG CD79A
39 ritscher-schinzel syndrome 1 10.1 CD40LG CD79A
40 diabetic angiopathy 10.1 CD40LG CD79A
41 endocarditis 10.1 CD40LG CD79A
42 muscular dystrophy 10.1 CD40LG CD79A
43 dumping syndrome 10.1 CD40LG CD79A
44 striatonigral degeneration 10.1 CD40LG CD79A
45 mononeuritis of upper limb 10.1 KLK3 MVD
46 nerve compression syndrome 10.1 CD40LG ECI1
47 ciliary body spindle cell melanoma 10.1 CD40LG CD79A
48 purulent endophthalmitis 10.1 CD40LG CD79A
49 mu chain disease 10.1 CD40LG CD79A
50 generalized atherosclerosis 10.1 CD40LG CD79A

Comorbidity relations with Urethral Syndrome via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Urethral Syndrome:



Diseases related to Urethral Syndrome

Symptoms & Phenotypes for Urethral Syndrome

UMLS symptoms related to Urethral Syndrome:


pain in urethra

Drugs & Therapeutics for Urethral Syndrome

Drugs for Urethral Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 346)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4,Phase 1 64-17-5 702
2
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3 51-43-4 5816
3
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
4
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
5
Tamsulosin Approved, Investigational Phase 4,Phase 3,Phase 2 106133-20-4 129211
6
Azithromycin Approved Phase 4,Phase 3,Phase 2 83905-01-5 55185 53477736 447043
7
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 564-25-0 54671203
8
Fesoterodine Approved Phase 4,Phase 2 286930-02-7, 286930-03-8 6918558
9
Lymecycline Approved Phase 4 992-21-2 5280963
10
Nitrofurantoin Approved, Vet_approved Phase 4 67-20-9 5353830
11
Doxazosin Approved Phase 4 74191-85-8 3157
12
Goserelin Approved Phase 4 65807-02-5 47725 5311128
13
Silodosin Approved Phase 4,Phase 2 160970-54-7
14
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
15
Dutasteride Approved, Investigational Phase 4,Phase 3 164656-23-9 152945 6918296
16
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 2180-92-9, 38396-39-3 2474
17
Sulfamethoxazole Approved Phase 4,Phase 2 723-46-6 5329
18
Oxybutynin Approved, Investigational Phase 4 5633-20-5 4634
19
Trimethoprim Approved, Vet_approved Phase 4,Phase 2 738-70-5 5578
20
Ropivacaine Approved Phase 4,Phase 3 84057-95-4 71273 175805
21
Alfuzosin Approved, Investigational Phase 4 81403-80-7 2092
22
Gemifloxacin Approved, Investigational Phase 4 175463-14-6 5464436 9571107
23
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
24
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
25
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2 58-05-9 54575, 6560146 143
26
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
27 Muscarinic Antagonists Phase 4,Phase 2,Phase 3,Phase 1
28 Cholinergic Agents Phase 4,Phase 2,Phase 3,Phase 1
29 Cholinergic Antagonists Phase 4,Phase 2,Phase 3,Phase 1
30 Adrenergic Agents Phase 4,Phase 2,Phase 3,Phase 1
31 Adrenergic Agonists Phase 4,Phase 2,Phase 3
32 Adrenergic Antagonists Phase 4,Phase 3,Phase 2
33 Adrenergic alpha-1 Receptor Antagonists Phase 4,Phase 3,Phase 2
34 Adrenergic alpha-Agonists Phase 4,Phase 2,Phase 3
35 Adrenergic alpha-Antagonists Phase 4,Phase 3,Phase 2
36 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1
37 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
38 Hormone Antagonists Phase 4,Phase 3,Phase 2
39 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1
40 Hormones Phase 4,Phase 3,Phase 2
41 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
42 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
43 Epinephryl borate Phase 4,Phase 2,Phase 3
44 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
45 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
46 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
47 Antimalarials Phase 4,Phase 3,Phase 2
48 Racepinephrine Phase 4,Phase 2,Phase 3
49 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
50 Autonomic Agents Phase 4,Phase 2,Phase 3

Interventional clinical trials:

(show top 50) (show all 448)
id Name Status NCT ID Phase
1 Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral Strictures Unknown status NCT01196572 Phase 4
2 An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Unknown status NCT00605319 Phase 4
3 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4
4 Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients Unknown status NCT02006303 Phase 4
5 TVT-Secur Versus TVT-Obturator: A Randomized Trial of Suburethral Sling Operative Procedures Unknown status NCT00676273 Phase 4
6 Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner Unknown status NCT01555047 Phase 4
7 Treatment of Female Stress Urinary Incontinence: Study Comparing Two Suburethral Slings, Retropubic Approach (TVT) and Trans-Obturator (TVT-O) Approach Unknown status NCT00135616 Phase 4
8 Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1 Completed NCT01661621 Phase 4
9 The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients Completed NCT00696761 Phase 4
10 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Completed NCT00147654 Phase 4
11 Efficacy of Combination Therapies for Gonorrhea Treatment Completed NCT00926796 Phase 4
12 Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy Completed NCT00934999 Phase 4
13 Prophylactic Antibiotics on Urethral Catheter Withdrawal Completed NCT00126698 Phase 4
14 A Randomized Controlled Study Comparing Three Single-incision Devices for Female Urinary Stress Incontinence Completed NCT00751088 Phase 4
15 Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Bladder Function Completed NCT02414373 Phase 4
16 TOMUS-Trial Of Mid-Urethral Slings Completed NCT00325039 Phase 4
17 Over Active Bladder Patients Having Sling Surgery Completed NCT00852696 Phase 4
18 Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence Completed NCT00734968 Phase 4
19 Global Performance Evaluation of the AMS CONTINUUM™ Device Completed NCT01083199 Phase 4
20 Post Market Clinical Study to Evaluate a Mid-Urethral Vaginal Tape Procedure With a Pre-Pubic Delivery Approach, for the Treatment of Stress Urinary Incontinence Completed NCT00688298 Phase 4
21 I-STOP TOMS - Trans Obturator Male Sling Completed NCT00442078 Phase 4
22 Uro-NIRS Clinical Study Completed NCT00706407 Phase 4
23 Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation Completed NCT00805701 Phase 4
24 Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) Completed NCT01747577 Phase 4
25 BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia Completed NCT01533038 Phase 4
26 Clinical Outcomes and Urodynamic Effects After Vaginal Tailored Mesh Surgery for Pelvic Organ Prolapse Completed NCT02178735 Phase 4
27 Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Completed NCT02296099 Phase 4
28 Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder Completed NCT01228370 Phase 4
29 Clinical and Urodynamic Effects of Minimally Laser (IncontiLaseTM) Procedure for Female Stress Urinary Incontinence Completed NCT02130375 Phase 4
30 Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence Completed NCT01194999 Phase 4
31 Quality of Life Intermittent Catheter Study Completed NCT01523743 Phase 4
32 Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence. Completed NCT01899794 Phase 4
33 PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate Completed NCT00527371 Phase 4
34 Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery Completed NCT01501565 Phase 4
35 Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH) Recruiting NCT02021032 Phase 4
36 Shock Wave Lithotripsy Versus Visual Cystolitholapaxy in The Management of Patients Presenting With Calcular Acute Urinary Retention: A Randomized Controlled Trial. Recruiting NCT02594631 Phase 4
37 Virtue® European Study Active, not recruiting NCT01608789 Phase 4
38 Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction Active, not recruiting NCT01741454 Phase 4
39 Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion Not yet recruiting NCT03151746 Phase 4
40 TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings Not yet recruiting NCT02867748 Phase 4
41 Gabapentin for Postop Pain After SSLF Not yet recruiting NCT03123861 Phase 4
42 Effects of Dexmedetomidine as Adjunct to Pudendal Block for Pediatric Penile Surgery Not yet recruiting NCT02848157 Phase 4
43 Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM] Terminated NCT01291264 Phase 4
44 Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach Terminated NCT00743535 Phase 4
45 Mixed Incontinence: Medical Or Surgical Approach? Terminated NCT00803270 Phase 4
46 Incontinence Ring on Stress Urinary Incontinence Terminated NCT00427778 Phase 4
47 Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA) Unknown status NCT01790776 Phase 3
48 A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection Unknown status NCT01697046 Phase 3
49 Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy Incontinence Unknown status NCT01540656 Phase 3
50 Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging Unknown status NCT01004211 Phase 3

Search NIH Clinical Center for Urethral Syndrome

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: urethral diseases

Genetic Tests for Urethral Syndrome

Genetic tests related to Urethral Syndrome:

id Genetic test Affiliating Genes
1 Abnormality of the Urethra 29

Anatomical Context for Urethral Syndrome

MalaCards organs/tissues related to Urethral Syndrome:

39
Testes, Prostate, Cervix

The Foundational Model of Anatomy Ontology organs/tissues related to Urethral Syndrome:

18
The Urethra

Publications for Urethral Syndrome

Articles related to Urethral Syndrome:

(show top 50) (show all 131)
id Title Authors Year
1
Gonococcal Conjunctivitis Despite Successful Treatment of Male Urethritis Syndrome. ( 26760182 )
2016
2
Epidemiology and laboratory characteristics of Trichomonas vaginalis infection in Croatian men with and without urethritis syndrome: a case-control study. ( 25568091 )
2015
3
A prospective study to evaluate the efficacy of cistiquer in improving lower urinary tract symptoms in females with urethral syndrome. ( 25034330 )
2014
4
The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. ( 21176078 )
2011
5
The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised? ( 18192290 )
2008
6
Treatment of urethral syndrome: a prospective randomized study with Nd:YAG laser. ( 16493214 )
2006
7
Urethral syndrome: response to alpha-adrenergic blocking agents. ( 16261427 )
2006
8
Treatment of post-menopausal urethral syndrome with the formula niao chang shu--a report of 40 cases. ( 15119161 )
2004
9
Dr. Li Yueqing's experience in treating female urethral syndrome. ( 15270256 )
2004
10
Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. ( 14665339 )
2003
11
Electric acupuncture in the treatment of 36 cases of female urethral syndrome. ( 14719301 )
2003
12
Transabdominal vesical sonography of urethral syndrome and stress incontinence. ( 12534925 )
2003
13
Treatment of female urethral syndrome refractory to antibiotics. ( 12402379 )
2002
14
The incidence of Chlamydia trachomatis in women with urethral syndrome. ( 11695072 )
2001
15
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Chlamydia trachomatis treated with azithromycin or doxycycline. ( 11330365 )
2001
16
Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. ( 11248610 )
2001
17
Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. ( 11822223 )
2001
18
Comparative analysis of azithromycin and doxycycline efficacy in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum. ( 10789560 )
2000
19
Duration of clinical symptoms in female patients with acute urethral syndrome caused by Ureaplasma urealyticum treated with azithromycin or doxycycline. ( 11154040 )
2000
20
Urinary bacterial flora of women with urethral syndrome and interstitial cystitis. ( 9852391 )
1999
21
Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. ( 10555247 )
1999
22
Urethral syndrome and associated risk factors related to obstetrics and gynecology. ( 10221602 )
1999
23
Study on acupuncture and moxibustion therapy for female urethral syndrome. ( 10437230 )
1998
24
Female urethral syndrome. A female prostatitis? ( 8686301 )
1996
25
1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. ( 8912627 )
1996
26
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. ( 7629982 )
1995
27
Evolving strategies for management of the nongonococcal urethritis syndrome. ( 7629989 )
1995
28
Urethral syndrome: clinical results with antibiotics alone or combined with estrogen. ( 7957464 )
1994
29
The urethral syndrome and its management. ( 7928838 )
1994
30
Fibromyalgia associated with female urethral syndrome. ( 8187451 )
1994
31
The urethral syndrome: a controlled evaluation. J Psychosom Res 1993; 37: 737-743. ( 8027965 )
1994
32
The urethral syndrome: a controlled evaluation. ( 8229904 )
1993
33
The urethral syndrome--why what we do works, or doesn't. ( 1479977 )
1992
34
Surgical repair of hypospadias in women with symptoms of urethral syndrome. ( 1569664 )
1992
35
A psychophysiological evaluation of female urethral syndrome: evidence for a muscular abnormality. ( 1625341 )
1992
36
Genitourinary manifestations of fibrositis: an increased association with the female urethral syndrome. ( 2319522 )
1990
37
The urethral syndrome: myth or reality? A commentary. ( 2233643 )
1990
38
Prostatodynia or painful male urethral syndrome? ( 2385883 )
1990
39
The painful bladder: urethral syndrome and interstitial cystitis. ( 2130959 )
1990
40
Interstitial cystitis and the urethral syndrome: a possible answer. ( 2670041 )
1989
41
Urethral syndrome: a study in psychosomatic urology. ( 2486388 )
1989
42
Pharmacokinetic data and therapeutic efficacy of miocamycin: serum, urinary and prostatic levels. Therapeutic aspects in acute urethral syndrome and non-gonococcal urethritis. ( 16312542 )
1989
43
Cryosurgery versus dilation and massage for the treatment of recurrent urethral syndrome. ( 2810238 )
1989
44
Urethral syndrome. A comparison of different treatment modalities. ( 2926732 )
1989
45
Sexually transmitted diseases in women with urethral syndrome. ( 2903082 )
1988
46
Efficacy of miocamycin in the therapy of non-specific genital infections (NSGI): non-gonococcal urethritis (NGU) and acute urethral syndrome (AUS). ( 3259948 )
1988
47
The urethral syndrome. ( 3055620 )
1988
48
The urethral syndrome. ( 3170107 )
1988
49
Urethral syndrome: patient suggestions. ( 3420419 )
1988
50
The acute urethral syndrome in routine practice. ( 3494789 )
1987

Variations for Urethral Syndrome

Expression for Urethral Syndrome

Search GEO for disease gene expression data for Urethral Syndrome.

Pathways for Urethral Syndrome

Pathways related to Urethral Syndrome according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.19 CD40LG CD79A

GO Terms for Urethral Syndrome

Biological processes related to Urethral Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 B cell proliferation GO:0042100 8.62 CD40LG CD79A

Molecular functions related to Urethral Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 carboxy-lyase activity GO:0016831 8.62 BCKDHA MVD

Sources for Urethral Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....